South Korea Swine Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Product (Inactivated and Modified/Attenuated Live), By Type (Pseudorabies and Porcine Circovirus Type 2), By Route of Administration (Injectables, Intranasal, and Oral), and South Korea Swine Vaccines Market Insights, Industry Trend, Forecasts to 2035

South Korea Swine Vaccines Market Insights Forecasts to 2035

• The South Korea Swine Vaccines Market Size Was Estimated at USD 34.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.88% from 2025 to 2035
• The South Korea Swine Vaccines Market Size is Expected to Reach USD 64.7 Million by 2035

According to a research report published by Spherical Insights and Consulting, The South Korea Swine Vaccines Market Size is anticipated to reach USD 64.7 Million by 2035, growing at a CAGR of 5.88% from 2025 to 2035. Its efficacy and efficiency in offering swine sustained defense against serious illnesses. Farmers may guarantee the well-being and efficiency of their herds with the help of injectable vaccines, such as those that target PCV2, Mycoplasma hyopneumoniae, and other common infections. For large-scale operations, these vaccinations are time and cost-effective since they usually require fewer doses and frequently offer prolonged protection with a single injection.

Market Overview

The selling of vaccines intended to prevent and treat swine (pig) diseases is included in the swine vaccines market. It is an essential component of the animal health sector, helping to maintain the well-being and output of pig populations, which contribute significantly to the world's meat supply. The immune system's ability to fight off illnesses, these vaccines help shield pigs from a variety of diseases, including bacteria, viruses, and parasites. Swine vaccines enhance herd health, reduce disease transmission, and improve pork quality, leading to increased productivity and economic stability in the swine industry. vaccine technology, such as mRNA and recombinant vaccines, presents opportunities for more effective and faster-acting solutions. Emerging markets in Asia-Pacific and Latin America offer significant growth potential due to rising demand for pork and increased investment in livestock health. Governments are promoting swine vaccination programs through subsidies, research funding, and regulatory support. For instance, the Brazilian government allocated funding to Embrapa Swine and Poultry for research on swine diseases, aiming to develop more effective vaccines.

Report Coverage

This research report categorizes the market for South Korea swine vaccines market based on various segments and regions forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea swine vaccines market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea swine vaccines market.

Driving Factors                  

The swine vaccine market is driven by increasing outbreaks of infectious diseases like African swine fever and porcine reproductive and respiratory syndrome, which threaten pork production. Rising demand for pork and stricter biosecurity measures in swine farming boost vaccine adoption. Technological advancements, such as innovative recombinant and mRNA vaccines, improve efficacy and reduce disease spread. Additionally, growing awareness among farmers about animal health and government support through vaccination programs further propel market growth, ensuring healthier herds and enhanced productivity.    

Restraining Factors        

High development and production costs make vaccines less accessible, especially for small-scale producers. Stringent regulatory requirements and lengthy approval processes can delay the introduction of new vaccines, limiting innovation. Concerns over vaccine safety and potential side effects may deter farmers from adopting vaccination programs. Additionally, logistical issues, such as maintaining the cold chain during distribution, can compromise vaccine efficacy, particularly in remote areas. These factors collectively pose significant barriers to the expansion of the swine vaccine market.

Market Segmentation

The South Korea Swine Vaccines Market share is classified into product, type, and route of administration.

• The inactivated segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea swine vaccines market is segmented by product into inactivated and modified/attenuated live. Among these, the inactivated segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. live-attenuated vaccines in terms of stability, affordability, and ease of availability. They stop the pathogens from replicating, they reduce the chance of virulence reversion following immunization. Additionally, it provides pigs with a quicker cell-mediated immune response and improved immunization. Adjuvants like aluminum hydroxide or certain oils can boost the immunity derived from inactivated (killed) food.

• The pseudorabies segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea swine vaccines market is segmented by type into pseudorabies and porcine circovirus type 2. Among these, the pseudorabies segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. RNA transcription is prone to intrinsic mistakes, the viral genome is highly heterogeneous. It is difficult to manage individual variability, even within the same nation.

• The injectables segment held a dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea swine vaccines market is segmented by route of administration into injectables, intranasal, and oral. Among these, the injectables segment held a dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period. Its efficacy and efficiency in offering swine sustained defense against serious illnesses. Farmers may guarantee the well-being and efficiency of their herds with the help of injectable vaccines, such as those that target PCV2, Mycoplasma hyopneumoniae, and other common infections. For large-scale operations, these vaccinations are time- and cost-effective since they usually require fewer doses and frequently offer prolonged protection with a single injection.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Swine Vaccines Market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GC Biopharma (Green Cross Corporation)
• Yuhan Corporation
• Hanmi Pharm
• SK Bioscience
• Samsung Biologics
• Celltrion
• KBNP Inc.
• Hanil Vaccine
• Daewoong Pharmaceutical
• Medytox
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea swine vaccines market based on the below-mentioned segments:

South Korea Swine Vaccines Market, By Product

• Inactivated
• Modified/Attenuated Live

South Korea Swine Vaccines Market, By Type

• Pseudorabies
• Porcine Circovirus Type 2

South Korea Swine Vaccines Market, By Route Of Administration

• Injectables
• Intranasal
• Oral